Family Office Of America (FOFA) EBITDA (2021 - 2026)
Family Office Of America's (FOFA) quarterly EBITDA came in at $274872.0 in Q1 2026, up 366.04% year-on-year from $58980.7 in Q1 2025, and up 213.06% quarter-over-quarter from -$243124.0 in Q4 2025.
Family Office Of America (FOFA) EBITDA (2021 - 2026) Analysis & Trends
Family Office Of America has disclosed EBITDA across 6 years of filings, most recently posting $274872.0 for Q1 2026.
- EBITDA for Q1 2026 came in at $274872.0, up 366.04% year-over-year; the trailing twelve-month figure through Mar 2026 was -$122739.0 (up 33.26% YoY), and the FY2025 annual result was -$501079.0, down 419.18% from the prior year.
- EBITDA came in at $274872.0 for Q1 2026 at Family Office Of America, up from -$243124.0 in the prior quarter.
- In the past five years, EBITDA ranged from a high of $1.5 million in Q4 2023 to a low of -$1.6 million in Q2 2023.
- The 5-year median for EBITDA is -$79811.0 (2023), against an average of -$86679.8.
- Across the five-year window, EBITDA surged 906.36% in 2023 and plunged 737.2% in 2025, its largest moves.
- Family Office Of America's EBITDA stood at -$188254.0 in 2022, then soared by 906.36% to $1.5 million in 2023, then tumbled by 101.91% to -$29040.0 in 2024, then sank by 737.2% to -$243124.0 in 2025, then soared by 213.06% to $274872.0 in 2026.
- The last three EBITDA figures came in at $274872.0 (Q1 2026), -$243124.0 (Q4 2025), and -$55169.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.46 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 663.81 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 255.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 316.80 Mn |
| 10 | Family Office Of America | - | - | 783,126.00 | 274,872.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 274,872.00 |
| Dec 31, 2025 | -243,124.00 |
| Sep 30, 2025 | -55,169.00 |
| Jun 30, 2025 | -99,318.00 |
| Mar 31, 2025 | -103,321.00 |
| Dec 31, 2024 | -29,040.00 |
| Sep 30, 2024 | -21,438.00 |
| Jun 30, 2024 | -30,102.00 |
| Mar 31, 2024 | -16,160.00 |
| Dec 31, 2023 | 1.52 Mn |
| Sep 30, 2023 | -28,572.00 |
| Jun 30, 2023 | -1.64 Mn |
| Mar 31, 2023 | -79,811.00 |
| Dec 31, 2022 | -188,254.00 |
| Sep 30, 2022 | -126,659.00 |
| Jun 30, 2022 | -510,529.00 |
| Mar 31, 2022 | -95,073.00 |
| Dec 31, 2021 | -243,216.00 |
| Sep 30, 2021 | -518,866.00 |
| Jun 30, 2021 | -622,777.00 |